Gefitinib in Combination With Chemoradiation in Resectable Gastric Cancer

Clinical trial NCT00237900 · TERMINATED

Trial details

NCT number: NCT00237900
Sponsor: AstraZeneca
Status: TERMINATED
Phase: Phase 1, Phase 2
Study type: INTERVENTIONAL

Subjects With Resectable Local or Locally Advanced, Non-Metastatic (T2-T4, N0-N3, M0; Stages II and III) and Histologically-Confirmed Intestinal GC

Start date: 2003-07-01
Enrollment: 34

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.